Issue #240
- Protease Inhibitors at Retroviruses Conference
- Protease Inhibitors in Human Testing: Annotated List
- Ritonavir (Abbott Protease Inhibitor) Proves Survival Benefit in Late-Stage AIDS
- Agouron Starts Phase III Protease Inhibitor Studies
- Vancouver International Conference: Community Booths Deadline Extended
- FDA Antiviral Advisory Committee Meetings
- Prisoners: Send Address Updates; Contacting Organizations
- NMAC Skills Building Conference in South Africa: Facilitators Wanted
- Computer Censorship Law, ACLU Test Case, Begin February 8
source: AIDS Treatment News
